Related Experiment Video
Updated: May 10, 2026
08:49
Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Ileitis after colectomy for ulcerative colitis or carcinoma
1Department of Gastroenterology, Tel Aviv Medical Center, Ichilov Hospital, Israel.
Gut
|March 1, 1994
Summary
A non-specific preanastomotic ileitis can develop years after colectomy for ulcerative colitis or carcinoma. This condition, affecting the ileum near the anastomosis, presents with varied symptoms and unknown causes, with azathioprine showing some treatment efficacy.
Area of Science:
- Gastroenterology and Surgical Oncology
- Inflammatory Bowel Disease Research
Background:
- Ileitis developing post-ileostomy is a known but infrequently discussed complication.
- Colectomy for ulcerative colitis or carcinoma often necessitates intestinal reconstruction, creating potential sites for complications.
Observation:
- Nine patients developed non-specific preanastomotic ileitis years after colectomy and various ileorectal or ileoanal reconstructions.
- The affected ileum exhibited inflammation, erosions, ulcerations, and strictures.
- Symptoms ranged from asymptomatic to severe pain and diarrhea; intestinal obstruction occurred in three patients.
Findings:
- No specific cause (granulomas, infections, ischemia) was identified for the ileitis.
- Anastomoses were consistently patent.
- Treatment with steroids, 5-aminosalicylic acid, and methotrexate yielded poor responses, while azathioprine was effective in three patients.
Implications:
- This preanastomotic ileitis, potentially more common than previously thought, requires further investigation into its etiology.
- Understanding the pathogenesis is crucial for developing targeted therapies beyond current limited options.
- The condition highlights the long-term complications associated with intestinal surgery and reconstruction.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...